Brivanib Catalog No.:M10926-10 2S)-2-phenylcyclopropyl)cyclohexane-1

2S)-2-phenylcyclopropyl)cyclohexane-1

BVN-972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON)

and 100 mg/kg

4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea

and TF in synovial fibroblasts

Brivanib Catalog No.:M10926-10 2S)-2-phenylcyclopropyl)cyclohexane-1Brivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Product information CAS